| 维持性血液透析患者甲状旁腺激素对重组人促红细胞生成素疗效的影响 |
| |
| 引用本文： | 王俊峰,李宏辉,李晓艳,林强,汪俊超,钟小艳,吴仁远,陈科.维持性血液透析患者甲状旁腺激素对重组人促红细胞生成素疗效的影响[J].西部医学,2011,23(10):1927-1929. |
| |
| 作者姓名： | 王俊峰 李宏辉 李晓艳 林强 汪俊超 钟小艳 吴仁远 陈科 |
| |
| 作者单位： | 成都军区机关医院肾病科,四川成都,610011 |
| |
| 摘 要： | 目的探讨维持性血液透析患者甲状旁腺激素（iPTH）对重组人促红细胞生成素（r-EPO）疗效的影响。方法 92例维持性血液透析患者于透析日空腹采血测定血红蛋白（Hb）、红细胞比积（Hct）、血清铁蛋白（SFe）、C反应蛋白（CRP）、血清钙（Ca）、磷（P）、血浆白蛋白（Alb）、血清肌酐（Cr）和iPTH,记录重组人促红细胞生成素（r-HuEPO）用量,r-EPO用量/Hct比值（EPO/Hct）作为r-EPO疗效的指标。结果 92例维持性血液透析患者中71例（占77.2%）iPTH升高（iPTH增高组）;21例（占22.8%）正常（iPTH正常组）,iPTH增高组EPO/Hct比值、P、Ca×P和iPTH水平均高于iPTH正常组,Hct、Hb低于iPTH正常组;多因素Logistic回归分析表明,影响EPO/Hc比值的因素有iPTH、P、年龄和透析疗程（R2=0.374,P=0.041）。结论继发性甲状旁腺功能亢进是尿毒症患者的常见并发症之一,甲状旁腺激素升高是降低重组人促红细胞生成素疗效的主要因素之一。
|
| 关 键 词： | 肾性贫血 血液透析 甲状旁腺激素 重组人促红细胞生成素 |
Clinical analysis of hemodialysis patients' parathyroid hormone on recombinant human erythropoietin |
| |
| WANG Jun-feng,LI Hong-hui,LI Xiao-yan,et al.Clinical analysis of hemodialysis patients' parathyroid hormone on recombinant human erythropoietin[J].Medical Journal of West China,2011,23(10):1927-1929. |
| |
| Authors: | WANG Jun-feng LI Hong-hui LI Xiao-yan |
| |
| Institution: | WANG Jun-feng,LI Hong-hui,LI Xiao-yan,et al(Department of Nephrology,Chengdu Military Region Institution Hospital,Chengdu 610011,China) |
| |
| Abstract: | Objective To explore influence of hemodialysis patients' parathyroid hormone on the effect of erythropoietin.Methods The Hb,Hct,SFe,CRP,Ca,P,Alb,Cr and iPTH of 92 cases of hemodialysis patients were tested at dialysis day.The amount of the r-HuEPO was recorded,and the ratio of the amount of r-HuEPO and Hc was considered as indication of the effect of r-EPO.Results The iPTH of 71 hemodialysis patients in 92 cases(amounts to be 77.2%) increased.The iPTH of 21 hemodialysis patients in 92 cases(amounts to be 22... |
| |
| Keywords: | Renal anemia Hemodialysis iPTH Recombinant human erythropoietin |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
